Patients | Number | % |
---|---|---|
Age (years; Mean) | 16 (range 4 – 39) | - |
Sex | ||
Male | 12 | 70.6% |
Female | 5 | 29.4% |
EWSR-ETS translocation | ||
No | 0 | 0 |
Yes | 13 | 76.5% |
Not available | 4 | 23.5% |
Primary site of the tumor | ||
Axialb | 6 | 42.9% |
Extremities | 8 | 57.1% |
Time from initially diagnosis of ES to extensive L/PMeta | ||
0 | 5 | 23.8% |
< 12 months | 4 | 19.0% |
> 12 months | 12 | 57.1% |
Chemotherapy regimen before CR/nCR | ||
VDC-IE | 5 | 23.8% |
VIT | 3 | 14.3% |
AVI | 13 | 61.9% |
Time from L/PMeta to CR/nCR (months; Mean) | 5.2 | - |
Lesions other than L/PMeta | ||
none | 17 | 81.0% |
Primary bone lesion | 4 | 19.0% |